IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 14,700
+160 (1.10%)
At close: Nov 5, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 220.82 billion as of November 5, 2026. It is the 21,588th most valuable company in the world and the 727th biggest in South Korea. Its market cap has decreased by 75.54% in one year.
Market Cap
220.82B
Enterprise Value
207.12B
Revenue
3.19B
Global Rank
Country Rank
#727 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 220.82B, a decrease of -55.15%. That is a compound annual growth rate of -42.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 220.82B | -74.35% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curocell | 354.79B |
| ROKIT Healthcare | 326.97B |
| AprilBio | 313.06B |
| Inventage Lab | 282.79B |
| S.Biomedics | 231.85B |
| HansBiomed | 231.75B |
| Genome & Company | 183.83B |
| IMBiologics | 182.79B |